Portside Wealth Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Buy
21,032
+1,051
+5% +$123K 0.31% 71
2026
Q1
$2.4M Sell
19,981
-4,038
-17% -$466K 0.33% 71
2025
Q4
$2.53M Sell
24,019
-452
-2% -$42.4K 0.34% 68
2025
Q3
$2.05M Buy
24,471
+3,179
+15% +$262K 0.28% 81
2025
Q2
$1.69M Buy
21,292
+939
+5% +$74.6K 0.25% 90
2025
Q1
$1.83M Buy
20,353
+170
+0.8% +$15.9K 0.3% 81
2024
Q4
$2.01M Buy
20,183
+3,774
+23% +$389K 0.33% 72
2024
Q3
$1.86M Buy
16,409
+1,459
+10% +$173K 0.32% 76
2024
Q2
$1.85M Sell
14,950
-1,620
-10% -$209K 0.35% 74
2024
Q1
$2.19M Sell
16,570
-1,211
-7% -$149K 0.4% 71
2023
Q4
$1.94M Sell
17,781
-826
-4% -$85.7K 0.36% 79
2023
Q3
$1.92M Buy
18,607
+603
+3% +$65K 0.36% 74
2023
Q2
$2.08M Buy
+18,004
New +$2.04M 0.39% 69

Other funds holding MRK

Portside Wealth Group's MRK Position: Q2 2026 in Review

Portside Wealth Group increased its Merck (MRK) stake by 5.3% in Q2 2026, buying an estimated $123K and bringing the position to 21,032 shares worth $2.7M. The position accounts for 0.31% of the portfolio, ranked #71.

Portside Wealth Group first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 2,521 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Portside Wealth Group held 21,032 shares of Merck worth $2.7M as of Q2 2026.
  • Portside Wealth Group bought 1,051 Merck shares in Q2 2026, an estimated $123K.
  • Merck made up 0.31% of Portside Wealth Group's portfolio in Q2 2026, its #71 holding.
  • Portside Wealth Group first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.